中国药物经济学2025，Vol.20Issue(2)：27-32,6.DOI:10.12010/j.issn.1673-5846.2025.02.005
数字化转型对医药企业绿色技术创新的异质性影响
Impact Heterogeneity of Digital Transformation on Green Technology Innovation of Pharmaceutical Enterprises
摘要
Abstract
Objective To analyze the impact heterogeneity of digital transformation on green technology innovation of pharmaceutical enterprises,so as to provide a reference for improving the digital level and green technology innovation of China's pharmaceutical manufacturing industry.Methods Based on the data of 272 listed pharmaceutical manufacturing enterprises from 2010 to 2022,the two-way fixed-effect model was used to empirically test the impact of digital transformation on green technology innovation of pharmaceutical manufacturing enterprises and the moderating effect of government subsidies.In addition,the heterogeneity was explored by combining regional differences,ownership differences,and differences in the lifecycle of enterprises.Results The digital transformation has significantly and positively promoted the green technology innovation capability of pharmaceutical manufacturing enterprises,with a regression coefficient of 0.125.Government subsidies can strengthen the positive relationship between digital transformation and green technology innovation,with a regression coefficient of 0.081.The heterogeneity test results indicated that the impact of the digital transformation on green innovation shows regional differences,ownership differences,and lifecycle differences.Conclusion The government and pharmaceutical companies should work together to promote digital transformation,stimulate innovation potential,and improve the efficiency of green innovation.关键词
医药制造业/数字化转型/绿色创新/政府补贴Key words
Pharmaceutical manufacturing/Digital transformation/Green innovation/Government subsidies分类
医药卫生引用本文复制引用
赵波,李亦兵,杨盼盼,刘文轩,熊雯,袁菊..数字化转型对医药企业绿色技术创新的异质性影响[J].中国药物经济学,2025,20(2):27-32,6.基金项目
江苏省研究生科研与实践创新计划项目(KYCX21_0690) （KYCX21_0690）
